Chun, F.K., Briganti, A., Gallina, A., Hutterer, G.C., Shariat, S.F., Antebie, E., et al. (2007) Prostate Specific Antigen Improves the Ability of Clinical Stage and Biopsy Gleason Sum to Predict the Pathologic Stage at Radical Prostatectomy in the New Millenium. European Urology, 52, 1067-1074.
http://dx.doi.org/10.1016/j.eururo.2007.03.018

has been cited by the following article:

• TITLE: Single Positive Core Prostate Cancer Has Less Aggressive Pathologic Features than Multiple Positive Core Prostate Cancer but Should It Still Be Considered an Indolent Tumor?

  AUTHORS: Ricardo Kupka, Marcos Francisco Dall’Oglio, Alexandre Crippa, José Pontes, Aguinel José Bastian Júnior, Luís Felipe Piovesan, Willian Nahas, Miguel Srougi

  KEYWORDS: Prostate Cancer, Active Surveillance, Radical Prostatectomy, Prostate Biopsy

  JOURNAL NAME: Open Journal of Urology, Vol.4 No.6, June 17, 2014

  ABSTRACT: Introduction: A single positive core (SPC) in a prostate biopsy is usually associated with indolent prostate cancer (PCa), and is considered one active surveillance criteria. To determine if a SPC should qualify a patient for surveillance, we compared the pathological findings for SPC and multiple positive core in a matched population who underwent radical prostatectomy (RP). Material and Methods: We evaluated 373 SPC patients who underwent RP (Group 1) and 375 consecutive cases with multiple positive core (Group 2) who were matched according to age, prostate weight, PSA level and clinical stage. In addition to preoperative data and epidemiological characteristics, we compared the rates of positive surgical margins (PSMs), extraprostatic extension (EPE) and seminal vesicle invasion (SVI) according to the Gleason scores (GSs) of the biopsies. Results: Both groups were similar according age, PSA level, prostate weight and clinical stage. Group 1 had a lower PSM rate (20.9% vs 37.6%, p